<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37115700</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e171350</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI171350</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsao</LastName><ForeName>Yen-Po</ForeName><Initials>YP</Initials></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Fang-Yu</ForeName><Initials>FY</Initials></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Chih-Wei</ForeName><Initials>CW</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ming-Han</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Yi-Chen</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Abdulkareem</LastName><ForeName>Babamale Olarewaju</ForeName><Initials>BO</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Se-Yi</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Wen-Ting</ForeName><Initials>WT</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Pei-Ching</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>I-Chun</ForeName><Initials>IC</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Pin-Hsuan</ForeName><Initials>PH</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chien-Sheng</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Chang-Youh</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Szu-Ting</ForeName><Initials>ST</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C476731">NLRP12 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>J Clin Invest. 2023 Feb 1;133(3):</RefSource><PMID Version="1">36719379</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37115700</ArticleId><ArticleId IdType="pmc">PMC10145918</ArticleId><ArticleId IdType="doi">10.1172/JCI171350</ArticleId><ArticleId IdType="pii">171350</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>